Which mode of transmission is associated with hepatitis A?

Choice A rationale:

The nurse should expect to assess fever in a client with suspected hepatitis A infection. Hepatitis A can cause flu-like symptoms, and fever is a common manifestation of the infection.

Choice C rationale:

Dark urine is another symptom the nurse should expect to assess in a client with hepatitis

A. Hepatitis A can cause jaundice, leading to dark-colored urine due to the accumulation of bilirubin in the bloodstream.

Choice D rationale:

Abdominal pain is a symptom that the nurse should anticipate in a client with hepatitis A infection. Hepatitis A can cause inflammation of the liver, leading to abdominal discomfort or pain in the right upper quadrant.

Choice E rationale:

Confusion is another possible symptom in a client with hepatitis

A. Severe cases of hepatitis A can lead to hepatic encephalopathy, causing confusion, altered mental status, and even coma.

A.

Choice A rationale:

Choice A is incorrect because the hepatitis A vaccine provides active immunity, not passive immunity. Active immunity means that the body produces its antibodies in response to the vaccine, providing long-term protection against the virus.

Choice B rationale:

The hepatitis A vaccine is indeed recommended for travelers to areas with high prevalence of hepatitis

A. It helps protect travelers from acquiring the virus through contaminated food and water in regions where hepatitis A is more common.

Choice C rationale:

Choice C is incorrect because the hepatitis A vaccine is effective in preventing hepatitis A in close contacts of infected individuals. Vaccination is a crucial preventive measure for those who are in close contact with infected individuals, as it can help halt the spread of the virus.

Choice D rationale:

Choice D is incorrect because the hepatitis A vaccine is not given within 12 hours of birth to newborns of hepatitis A positive mothers. The vaccination schedule for hepatitis A vaccine varies depending on the country's recommendations but is typically given starting at 12-23 months of age.